Literature DB >> 5726825

Vasodilating and alpha-receptor blocking activity of a new ergoline derivative.

G Arcari, L Dorigotti, G B Fregnan, A H Glässer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5726825      PMCID： PMC1703471     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  4 in total

1.  A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat.

Authors:  J S Gillespie; T C Muir
Journal:  Br J Pharmacol Chemother       Date:  1967-05

2.  1-Methyl-8-beta-carbobenzyloxy-aminomethyl-10-alpha-ergoline, a potent and long-lasting 5-hydroxytryptamine antagonist.

Authors:  C Beretta; R Ferrini; A H Glässer
Journal:  Nature       Date:  1965-07-24       Impact factor: 49.962

3.  The pharmacological actions of (m-hydroxyphenethyl) trimethylammonium (leptodactyline).

Authors:  V ERSPAMER; A GLASSER
Journal:  Br J Pharmacol Chemother       Date:  1960-03

4.  Structure-activity relationship of various acyl derivatives of 6-methyl-8 beta-aminomethyl-10 alpha-ergoline (dihydrolysergamine).

Authors:  G B Fregnan; A H Glässer
Journal:  Experientia       Date:  1968-02-15
  4 in total
  6 in total

1.  The effects of catecholamines and adrenoceptor blocking drugs on the canine peripheral lymph flow.

Authors:  P De Micheli; A H Glässer
Journal:  Br J Pharmacol       Date:  1975-04       Impact factor: 8.739

2.  Effect of nicergoline on cerebral blood flow.

Authors:  L D Iliff; G H Du Boulay; J Marshall; R W Russell; L Symon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-08       Impact factor: 10.154

3.  10-Methoxyergoline derivatives as -adrenergic blocking agents.

Authors:  G Arcari; L Bernardi; G Bosisio; S Coda; G B Fregnan; A H Glässer
Journal:  Experientia       Date:  1972-07-15

4.  The effect of nicergoline on the lower urinary tract muscle.

Authors:  M Caine; B Mazouz; B M Rossini
Journal:  Urol Res       Date:  1984

5.  Symptomatic treatment of benign prostatic obstruction with nicergoline: a placebo controlled clinical study and urodynamic evaluation.

Authors:  F Ronchi; A Margonato; R Ceccardi; P Rigatti; B M Rossini
Journal:  Urol Res       Date:  1982

Review 6.  Therapeutic use of nicergoline.

Authors:  Bengt Winblad; Mario Fioravanti; Tomas Dolezal; Inara Logina; Ivan Gospodinov Milanov; Dinu Cristian Popescu; Alina Solomon
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 3.580
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.